CMPS - Compass Pathways - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

259M

Cash

117.1M

Avg Qtr Burn

-27.51M

Short % of Float

0.00%

Insider Ownership

45.43%

Institutional Own.

20.83%

Qtr Updated

03/31/23

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
COMP360 (Psilocybin) Details Treatment Resistant Depression	Phase 3 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
COMP360 (Psilocybin) Details Post-traumatic stress disorder (PTSD)	Phase 2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
COMP360 (Psilocybin) Details Anorexia nervosa	Phase 2 Interim update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.